CGREF1 and glioblastoma: CGR11 showed high expression in bladder, breast, colon, kidney, esophageal, liver, lung, prostate, rectal, and gastric cancers, while showing low expression in glioblastoma, head and neck, thyroid, and uterine cancers (Figure 1A).